• Publications
  • Influence
ALK and ROS1 as a joint target for the treatment of lung cancer: a review.
Rearrangements of the anaplastic lymphoma kinase (ALK) have been described in multiple malignancies, including non-small cell lung cancer (NSCLC). ALK fusions have gain of function properties whileExpand
  • 25
  • 3
Porphycenes: facts and prospects in photodynamic therapy of cancer.
The photodynamic process induces cell damage and death by the combined effect of a photosensitizer (PS), visible light, and molecular oxygen, which generate singlet oxygen ((1)O(2)) and otherExpand
  • 131
  • 1
Discovery of Novel Non‐Cyclam Polynitrogenated CXCR4 Coreceptor Inhibitors
HIV cell fusion and entry have been validated as targets for therapeutic intervention against infection. Bicyclams were the first low‐molecular‐weight compounds to show specific interaction withExpand
  • 17
  • 1
Solid-phase synthesis of a combinatorial library of dihydroceramide analogues and its activity in human alveolar epithelial cells.
Solid-phase synthesis of a small combinatorial library of dihydroceramide analogues as mixtures of erythro and threo diastereomers is described. Some dihydroceramide analogues cause growth arrest andExpand
  • 17
  • 1
Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma
BackgroundPharmacological inhibition of B cell receptor (BCR) signaling has recently emerged as an effective approach in a wide range of B lymphoid neoplasms. However, despite promising clinicalExpand
  • 7
  • 1
Ribosomal proteins EL11 from Escherichia coli and L15 from Saccharomyces cerevisiae bind to the same site in both yeast 26 S and mouse 28 S rRNA.
The heterologous interaction of Escherichia coli ribosomal protein EL11 with yeast 26 S and mouse 28 S rRNA was studied by analysing the ability of this protein to form a specific complex withExpand
  • 57
Comparison of Ligand-Based and Receptor-Based Virtual Screening of HIV Entry Inhibitors for the CXCR4 and CCR5 Receptors Using 3D Ligand Shape Matching and Ligand-Receptor Docking
A detailed comparison of receptor-based and ligand-based virtual screening approaches to find CXCR4 and CCR5 antagonists that could potentially serve as HIV entry inhibitors. Expand
  • 65
APIF: A New Interaction Fingerprint Based on Atom Pairs and Its Application to Virtual Screening
We present a new interaction fingerprint called APIF (atom-pairs-based interaction fingerprint) that encodes ligand-protein binding modes in a bit string based on the concept of atom pairs. Expand
  • 61
Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening
The process of HIV entry begins with the binding of the viral envelope glycoprotein gp120 to both the CD4 receptor and one of CXCR4 or CCR5 chemokine coreceptors. Expand
  • 34
Clustering and Classifying Diverse HIV Entry Inhibitors Using a Novel Consensus Shape-Based Virtual Screening Approach: Further Evidence for Multiple Binding Sites within the CCR5 Extracellular Pocket
HIV entry inhibitors have emerged as a new generation of antiretroviral drugs that block viral fusion with the CXCR4 and CCR5 membrane coreceptors. Expand
  • 30